Literature DB >> 7107409

In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificity.

R M Sutherland, P Keng, P J Conroy, D McDermott, B J Bareham, W Passalacqua.   

Abstract

The hypoxic cytotoxicity of four different 2-nitroimidazoles of similar electron affinities but different lipophilicities was compared using EMT6/Ro mouse mammary tumor cells in exponential growth phase in severely (less than 20 ppm) hypoxic conditions. The relative cytotoxicities were misonidazole (MISO) = desmethylmisonidazole (9963) greater than SR-2508 much greater than SR-2555 indicating that the compounds with the lowest lipophilicity were less cytotoxic. The rates of uptake of these compounds were MISO greater than 9963 greater than SR-2508 = SR-2555. These data together with comparisons of the amounts of cell-associated compounds indicate that the similarity in toxicity of MISO and 9963 can be related to a general similarity in their pharmacokinetics, but that other unknown factors must be considered to explain the relative toxicity of SR-2508 and SR-2555. In other experiments, EMT6/Ro cells synchronized using centrifugal elutriation were most sensitive in hypoxia to MISO at the late G1--early S phase of the cell cycle. These data indicate the importance of considering cellular and subcellular distribution of these nitroimidazoles as well as possible cell cycle specificity for cytotoxicity in interpreting relative effectiveness of different compounds in responses of mixed populations of cells in cultures or tumors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107409     DOI: 10.1016/0360-3016(82)90726-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Modulation of the tumor vasculature and oxygenation to improve therapy.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

2.  Oxygen regulated 80 kDa protein and glucose regulated 78kDa protein are identical.

Authors:  D E Roll; B J Murphy; K R Laderoute; R M Sutherland; H C Smith
Journal:  Mol Cell Biochem       Date:  1991-05-15       Impact factor: 3.396

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Apoptosis and 1-methyl-2-nitroimidazole toxicity in CHO cells.

Authors:  C B Brezden; R A McClelland; A M Rauth
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Changes in growth characteristics and macromolecular synthesis on recovery from severe hypoxia.

Authors:  R E Wilson; P C Keng; R M Sutherland
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

6.  Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism.

Authors:  C S Heacock; R M Sutherland
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

7.  Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.

Authors:  K Sakata; T T Kwok; B J Murphy; K R Laderoute; G R Gordon; R M Sutherland
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

Review 8.  The impact of hypoxia and its modification of the outcome of radiotherapy.

Authors:  Michael R Horsman; Jens Overgaard
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

9.  Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability.

Authors:  N M Hasan; G E Adams; M C Joiner; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.

Authors:  C Grau; S M Bentzen; J Overgaard
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.